MALIGNANT ATROPHIC PAPULOSIS

This adverse event was reported 40 times

These drugs are most commonly taken by patients reporting MALIGNANT ATROPHIC PAPULOSIS:

# Drug Count
0 ECULIZUMAB 21
1 TREPROSTINIL 20
2 ASPIRIN 8
3 ASPIRIN 325 MG 8
4 ASPIRIN 81 MG 8
5 METOPROLOL TARTRATE 6
6 TOCILIZUMAB 6
7 APIXABAN 5
8 CYCLOPHOSPHAMIDE 5
9 CYCLOPHOSPHAMIDE FOR INJECTION 5
See all common drugs associated with MALIGNANT ATROPHIC PAPULOSIS

MALIGNANT ATROPHIC PAPULOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SMOFLIPID 1 0.0011
1 DIPYRIDAMOLE 4 0.0011
2 PENTOXIFYLLINE 4 0.0009
3 PENICILLIN V POTASSIUM 1 0.0004
4 ECULIZUMAB 21 0.0004
5 BARICITINIB 1 0.0003
6 NADOLOL 2 0.0003
7 PROPAFENONE 1 0.0002
8 TREPROSTINIL 20 0.0002
9 TOFACITINIB CITRATE 1 0.0001
See all drugs enriched for association with MALIGNANT ATROPHIC PAPULOSIS

MALIGNANT ATROPHIC PAPULOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Blood Viscosity Reducer [EPC] 4 0.0009
1 Complement Inhibitor [EPC] 22 0.0004
2 Lipid Emulsion [EPC] 1 0.0004
3 Prostacycline Vasodilator [EPC] 20 0.0001
4 Interleukin-6 Receptor Antagonist [EPC] 6 0.0000
5 Factor Xa Inhibitor [EPC] 6 0.0000
6 Alkylating Drug [EPC] 5 0.0000
7 Janus Kinase Inhibitor [EPC] 3 0.0000
8 Platelet Aggregation Inhibitor [EPC] 9 0.0000
9 beta-Adrenergic Blocker [EPC] 3 0.0000
See all drug classes enriched for association with MALIGNANT ATROPHIC PAPULOSIS